Smith & Nephew acquires ArthroCare for $1.7B (4.5 X sales)

Smith & Nephew strengthens global sports medicine business through agreement to acquire ArthroCare for $1.7 billion (press release)
Smith & Nephew plc the global medical technology business, today announces the execution of a definitive agreement to acquire medical device company ArthroCare Corp. (NASDAQ: ARTC) for $48.25 per ArthroCare share in cash, a total consideration of approximately $1.7 billion and an enterprise value of $1.5 billion.
Commenting, Olivier Bohuon, Chief Executive Officer of Smith & Nephew, said:
“This is a compelling opportunity to add ArthroCare’s technology...